Zhejiang Huahai Pharmaceutical Co Ltd (600521) — Cash Flow-to-Debt Ratio
Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥282.81 Million could theoretically repay 0% of its total liabilities (CN¥11.55 Billion) in one year. Explore Zhejiang Huahai Pharmaceutical Co Ltd (600521) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. Also explore balance sheet size of Zhejiang Huahai Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Year-by-year debt coverage analysis for Zhejiang Huahai Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Zhejiang Huahai Pharmaceutical Co Ltd (600521) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥1.23 Billion | CN¥12.05 Billion | ▼ -47.2% |
| 2024 | 0.19x | CN¥2.17 Billion | CN¥11.24 Billion | ▼ -9.8% |
| 2023 | 0.21x | CN¥2.22 Billion | CN¥10.35 Billion | ▲ +79.4% |
| 2022 | 0.12x | CN¥1.24 Billion | CN¥10.41 Billion | ▲ +10.6% |
| 2021 | 0.11x | CN¥938.43 Million | CN¥8.69 Billion | ▼ -56.5% |
| 2020 | 0.25x | CN¥1.56 Billion | CN¥6.27 Billion | ▼ -29.9% |
| 2019 | 0.35x | CN¥1.75 Billion | CN¥4.95 Billion | ▲ +3114.7% |
| 2018 | 0.01x | CN¥67.90 Million | CN¥6.16 Billion | ▼ -93.5% |
| 2017 | 0.17x | CN¥546.24 Million | CN¥3.21 Billion | ▼ -15.6% |
| 2016 | 0.20x | CN¥433.10 Million | CN¥2.15 Billion | ▲ +85.3% |
| 2015 | 0.11x | CN¥195.31 Million | CN¥1.80 Billion | ▼ -58.8% |
| 2014 | 0.26x | CN¥328.61 Million | CN¥1.24 Billion | ▼ -22.0% |
| 2013 | 0.34x | CN¥490.29 Million | CN¥1.45 Billion | ▲ +76.2% |
| 2012 | 0.19x | CN¥243.83 Million | CN¥1.27 Billion | ▲ +2.0% |
| 2011 | 0.19x | CN¥197.51 Million | CN¥1.05 Billion | ▼ -53.7% |
| 2010 | 0.41x | CN¥299.47 Million | CN¥735.92 Million | ▼ -33.0% |
| 2009 | 0.61x | CN¥317.44 Million | CN¥522.98 Million | ▲ +198.8% |
| 2008 | 0.20x | CN¥84.20 Million | CN¥414.51 Million | ▼ -57.2% |
| 2007 | 0.47x | CN¥136.52 Million | CN¥287.78 Million | ▲ +36.2% |
| 2006 | 0.35x | CN¥77.54 Million | CN¥222.66 Million | ▲ +12.8% |
| 2005 | 0.31x | CN¥53.30 Million | CN¥172.70 Million | ▼ -79.3% |
| 2004 | 1.49x | CN¥163.73 Million | CN¥110.03 Million | ▲ +180.2% |
| 2003 | 0.53x | CN¥47.41 Million | CN¥89.27 Million | ▲ +18.2% |
| 2002 | 0.45x | CN¥75.34 Million | CN¥167.62 Million | ▲ +81.8% |
| 2001 | 0.25x | CN¥37.51 Million | CN¥151.72 Million | — |